I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Study protocol:
Kristian Elersič
;
Anamarija Banjac
;
Marko Živin
.
doi:10.1371/journal.pone.0299379.g001. , 2024
Link:
https://doi.org/10.1371/journal.pone.0299379.g001
RT Journal T1
Study protocol
UL https://suche.suub.uni-bremen.de/peid=base-ftgriffithunifig:oai:figshare.com:article_25327063&Exemplar=1&LAN=DE A1 Kristian Elersič A1 Anamarija Banjac A1 Marko Živin A1 Maja Zorović YR 2024 K1 Biochemistry K1 Microbiology K1 Genetics K1 Molecular Biology K1 Neuroscience K1 Physiology K1 Pharmacology K1 Biotechnology K1 Mental Health K1 Infectious Diseases K1 Virology K1 subcutaneously treated repeatedly K1 male wistar rats K1 gained significant attention K1 examined locomotor stimulation K1 xlink "> ketamine K1 upon repeated administration K1 undesirable side effects K1 repeated intermittent treatment K1 racemic ketamine resulted K1 stronger behavioral effect K1 ketamine doses produced K1 either 5 mg K1 repeated treatment K1 racemic ketamine K1 last administration K1 ketamine enantiomers K1 first treatment K1 first administration K1 behavioral effects K1 30 mg K1 locomotor sensitization K1 tolerance induced K1 three weeks K1 subanesthetic doses K1 stimulated locomotion K1 significantly weaker K1 rearing ) K1 preclinical study K1 natural behaviors K1 indicating tolerance K1 behavioral sensitization K1 ataxic effects K1 also associated K1 acting antidepressant JF doi:10.1371/journal.pone.0299379.g001 LK http://dx.doi.org/https://doi.org/10.1371/journal.pone.0299379.g001 DO https://doi.org/10.1371/journal.pone.0299379.g001 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)